← All diseases

Disease Atlas / Disease detail

Muscle tissue disorder

Muscle tissue disorders constitute a broad category of diseases with diverse causes and courses, manifesting from muscle weakness and pain to functional limitations.

muscle tissue disorder · disease of muscle organ · disease of muscle tissue · disease or disorder of muscle organ · disease or disorder of muscle tissue · disorder of muscle organ · disorder of muscle tissue · muscle organ disease · muscle organ disease or disorder · muscle tissue disease · muscle tissue disease or disorder · muscular disorder

MONDO:0003939Public QA completeSource-bound · 4

Disease at a glance

Start with the essentials, then explore the patient and research views.

Public revision · a6eec3cd9d24

Disease category
Muscle tissue disorders are a broad category encompassing various diseases and conditions affecting the muscles, and the MONDO entry itself is a classification item not confirmed as a specific clinical diagnosis.
Core mechanism
Known related factors include injury/overuse, genetic diseases, cancer, inflammation, neurological diseases, infections, and certain drugs, though there are also cases where the cause cannot be identified.
Main causes · related factors
Muscle disorders can reduce movement and strength due to abnormalities in the structure, energy production, or contractile function of the muscles themselves, or in the nerves, immune, and inflammatory processes that regulate the muscles.
Representative patterns
Representative clinical manifestations are muscle weakness and myalgia, and in severe cases, limitations in movement or paralysis may occur.
Individual differences
Symptoms and severity vary by individual depending on the cause, the extent of the affected muscles, age of onset, genetic background, comorbidities, and drug exposure.
Diagnosis
The natural course varies by cause: it may occur suddenly and improve, or recur, persist, and progressively worsen; therefore, changes in symptoms and functional decline are monitored together.
Management
Diagnosis is based on medical history and neurological and muscle strength examinations, combining blood tests, electromyography/nerve conduction studies, imaging, genetic testing, or muscle biopsy as needed.
Treatment/Research Status
It is difficult to definitively determine the cause or severity from a single test result, and normal results do not rule out all muscle disorders; therefore, symptoms, examinations, and the timing of tests must be interpreted together.
Read Evidence
Management includes adjusting triggers, rehabilitation and exercise planning, pain and fatigue control, and assessment of complications such as falls, respiration, and swallowing, tailored to the cause and functional status.
Key Precautions
There is no single standard treatment applicable to all muscle tissue disorders; treatment varies depending on the possibility of cause-specific therapy, progression patterns, and functional and safety issues.

For patients and families

A structured guide for understanding the disease and preparing for clinical conversations.

At a Glance

Muscle tissue disorders are a broad category encompassing various diseases and conditions affecting the muscles, and the MONDO entry itself is a classification item not confirmed as a specific clinical diagnosis.

Representative clinical manifestations are muscle weakness and myalgia, and in severe cases, limitations in movement or paralysis may occur.

How the disease works

Known related factors include injury/overuse, genetic diseases, cancer, inflammation, neurological diseases, infections, and certain drugs, though there are also cases where the cause cannot be identified.

Muscle disorders can reduce movement and strength due to abnormalities in the structure, energy production, or contractile function of the muscles themselves, or in the nerves, immune, and inflammatory processes that regulate the muscles.

Variations in presentation among individuals

Symptoms and severity vary by individual depending on the cause, the extent of the affected muscles, age of onset, genetic background, comorbidities, and drug exposure.

The broad framework of diagnosis and management

The natural course varies by cause: it may occur suddenly and improve, or recur, persist, and progressively worsen; therefore, changes in symptoms and functional decline are monitored together.

Diagnosis is based on medical history and neurological and muscle strength examinations, combining blood tests, electromyography/nerve conduction studies, imaging, genetic testing, or muscle biopsy as needed.

Current status of treatment

It is difficult to definitively determine the cause or severity from a single test result, and normal results do not rule out all muscle disorders; therefore, symptoms, examinations, and the timing of tests must be interpreted together.

Management includes adjusting triggers, rehabilitation and exercise planning, pain and fatigue control, and assessment of complications such as falls, respiration, and swallowing, tailored to the cause and functional status.

There is no single standard treatment applicable to all muscle tissue disorders; treatment varies depending on the possibility of cause-specific therapy, progression patterns, and functional and safety issues.

How to read clinical trials

Clinical trials must be interpreted by verifying the study design, target population, disclosure of results, and follow-up period; a completed status alone cannot be used to infer positive results.

Points to verify during clinical consultations

In clinical practice, the onset and changes in symptoms, triggers, distribution of muscle weakness and pain, medications taken, infections and injuries, family history, test results, and changes in daily function are assessed.

Medical Guidance

This material is for educational purposes only and is not intended as guidance for individual diagnosis or treatment. Please consult a healthcare professional if symptoms occur or worsen.

Evidence and sources

A trial registry status does not establish efficacy or regulatory approval.